These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 30875349

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Case Report of acute myeloid leukemia with "WT1, ATRX, CEBPA, CSMD1, IKZF1, and LRP1B mutation and translocation between chromosome 1 and 19" developing from Philadelphia-negative chronic myeloid leukemia after TKI therapy.
    Zhu H, Yang B, Liu J, Wu W, Ling Y.
    Medicine (Baltimore); 2020 Jan; 99(3):e18888. PubMed ID: 32011516
    [Abstract] [Full Text] [Related]

  • 8. The Impact of Tyrosine Kinase Inhibitors on Chronic Myeloid Leukemia Stem Cells and the Implication in Discontinuation.
    Jiang L, Wang H, Zhu X, Liu W, Zhou S, Geng Z, Xiao Y, Zou P, You Y, Li Q, Zhu X.
    Stem Cells Dev; 2019 Nov 15; 28(22):1480-1485. PubMed ID: 31530245
    [Abstract] [Full Text] [Related]

  • 9. Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring.
    Jabbour E, Kantarjian H.
    Am J Hematol; 2020 Jun 15; 95(6):691-709. PubMed ID: 32239758
    [Abstract] [Full Text] [Related]

  • 10. Dynamics of cytogenetic aberrations in Philadelphia chromosome positive and negative hematopoiesis during dasatinib therapy of chronic myeloid leukemia patients after imatinib failure.
    Fabarius A, Haferlach C, Müller MC, Erben P, Lahaye T, Giehl M, Frank O, Seifarth W, Hehlmann R, Hochhaus A.
    Haematologica; 2007 Jun 15; 92(6):834-7. PubMed ID: 17550857
    [Abstract] [Full Text] [Related]

  • 11. Disappearance of Bone Marrow Fibrosis in a Patient with Chronic Myeloid Leukemia Treated with Dasatinib.
    Vigna E, Martino B, Bacci F, Recchia AG, Mendicino F, Morelli R, Mauro FR, Musolino C, Greco R, Lucia E, Sabattini E, Morabito F, Gentile M.
    Chemotherapy; 2017 Jun 15; 62(6):350-352. PubMed ID: 28743118
    [Abstract] [Full Text] [Related]

  • 12. Transient presence of clonal chromosomal aberrations in Ph-negative cells in patients with chronic myeloid leukemia remaining in deep molecular response on tyrosine kinase inhibitor treatment.
    Gniot M, Lewandowski K, Ratajczak B, Lewandowska M, Lehmann-Kopydłowska A, Jarmuż-Szymczak M, Komarnicki M.
    Cancer Genet; 2014 Jun 15; 207(10-12):503-10. PubMed ID: 25496750
    [Abstract] [Full Text] [Related]

  • 13. Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.
    O'Dwyer ME, Gatter KM, Loriaux M, Druker BJ, Olson SB, Magenis RE, Lawce H, Mauro MJ, Maziarz RT, Braziel RM.
    Leukemia; 2003 Mar 15; 17(3):481-7. PubMed ID: 12646934
    [Abstract] [Full Text] [Related]

  • 14. Development of Philadelphia chromosome-negative acute myeloid leukemia with IDH2 and NPM1 mutations in a patient with chronic myeloid leukemia who showed a major molecular response to tyrosine kinase inhibitor therapy.
    Nakamura F, Arai H, Nannya Y, Ichikawa M, Furuichi S, Nagasawa F, Takahashi W, Handa T, Nakamura Y, Tanaka H, Nakamura Y, Sasaki K, Miyano S, Ogawa S, Mitani K.
    Int J Hematol; 2021 Jun 15; 113(6):936-940. PubMed ID: 33400143
    [Abstract] [Full Text] [Related]

  • 15. Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells.
    Larsson N, Billström R, Lilljebjörn H, Lassen C, Richter J, Ekblom M, Fioretos T.
    Cancer Genet Cytogenet; 2010 Jun 15; 199(2):89-95. PubMed ID: 20471511
    [Abstract] [Full Text] [Related]

  • 16. [Philadelphia chromosome-negative myeloid neoplasms in patients with Philadelphia chromosome-positive chronic myeloid leukemia during tyrosine kinase inhibtor-therapy].
    Yuan T, Wang XY, Lai YY, Qin YZ, Shi HX, Huang XJ, Jiang Q.
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jul 14; 40(7):547-553. PubMed ID: 32397016
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.